Literature DB >> 31269387

Hepatocellular Carcinoma. Reply.

Augusto Villanueva1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31269387     DOI： 10.1056/NEJMc1906565

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Limitations of Nerve Fiber Density as a Prognostic Marker in Predicting Oncological Outcomes in Hepatocellular Carcinoma.

Authors:  Jan Bednarsch; Xiuxiang Tan; Zoltan Czigany; Georg Wiltberger; Roman David Buelow; Peter Boor; Sven Arke Lang; Tom Florian Ulmer; Ulf Peter Neumann; Lara Rosaline Heij
Journal:  Cancers (Basel)       Date:  2022-04-29       Impact factor: 6.575

2.  Dual-Effect of Magnetic Resonance Imaging Reporter Gene in Diagnosis and Treatment of Hepatocellular Carcinoma.

Authors:  Jiaping Zhou; Qiaomei Zhou; Gaofeng Shu; Xiaojie Wang; Yuanfei Lu; Haiyan Chen; Tingting Hu; Jinsong Cai; Yongzhong Du; Risheng Yu
Journal:  Int J Nanomedicine       Date:  2020-09-30

3.  The oncogene Mct-1 promotes progression of hepatocellular carcinoma via enhancement of Yap-mediated cell proliferation.

Authors:  Wenjie Yang; Yong Ni; Shikun Yang; Yang Ji; Xinchen Yang; Feng Cheng; Xuehao Wang; Feng Zhang; Jianhua Rao
Journal:  Cell Death Discov       Date:  2021-03-22

4.  Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway.

Authors:  Jiejun Hu; Dong Cai; Zhibo Zhao; Guo-Chao Zhong; Jianping Gong
Journal:  Front Oncol       Date:  2021-04-16       Impact factor: 6.244

5.  Safranal Inhibits Angiogenesis via Targeting HIF-1α/VEGF Machinery: In Vitro and Ex Vivo Insights.

Authors:  Ali Abdalla; Chandraprabha Murali; Amr Amin
Journal:  Front Oncol       Date:  2022-02-02       Impact factor: 6.244

6.  Analysis of Related Risk Factors of Microvascular Invasion in Hepatocellular Carcinoma.

Authors:  Longqing Shi; Zhen Qu; Yue Yang; Yue Zhang; Donglin Sun
Journal:  Comput Math Methods Med       Date:  2022-03-21       Impact factor: 2.238

7.  Recurrence of Early Hepatocellular Carcinoma after Surgery May Be Related to Intestinal Oxidative Stress and the Development of a Predictive Model.

Authors:  Yongfei He; Tianyi Liang; Zijun Chen; Shutian Mo; Yuan Liao; Qiang Gao; Ketuan Huang; Tao Peng; Weijie Zhou; Chuangye Han
Journal:  Oxid Med Cell Longev       Date:  2022-10-04       Impact factor: 7.310

8.  Carbohydrate Sulfotransferase 4 Inhibits the Progression of Hepatitis B Virus-Related Hepatocellular Carcinoma and Is a Potential Prognostic Marker in Several Tumors.

Authors:  Longshan Zhang; Yao Fan; Xiaoqing Wang; Mi Yang; XiXi Wu; Weiqiang Huang; Jin Lan; Liwei Liao; Wenqi Huang; Lu Yuan; Hua Pan; Yuting Wu; Longhua Chen; Jian Guan
Journal:  Front Oncol       Date:  2020-10-15       Impact factor: 6.244

9.  Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma.

Authors:  Marie Dupuy; Sarah Iltache; Benjamin Rivière; Alexandre Prieur; George Philippe Pageaux; José Ursic Bedoya; Stéphanie Faure; Heloïse Guillaumée; Eric Assenat
Journal:  Cancers (Basel)       Date:  2022-01-13       Impact factor: 6.639

10.  A miR-212-3p/SLC6A1 Regulatory Sub-Network for the Prognosis of Hepatocellular Carcinoma.

Authors:  Dan-Dan Zhang; Wen-Er Wang; Yu-Shui Ma; Yi Shi; Jie Yin; Ji-Bin Liu; Xiao-Li Yang; Rui Xin; Da Fu; Wen-Jie Zhang
Journal:  Cancer Manag Res       Date:  2021-06-28       Impact factor: 3.989
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.